Adolescent antiretroviral management: Understanding the complexity of non-adherence

This case-based discussion highlights challenges in adolescent antiretroviral management, focusing on non-disclosure of status and the subsequent impact of suboptimal treatment adherence. Despite the scale-up of antiretroviral therapy (ART) and recommendations made by the World Health Organization (WHO) for ART for all human immunodeficiency virus (HIV)-infected paediatric patients, ART coverage in adolescents lags behind that in adults. Challenges of sustaining lifelong ART in children and adolescents require consideration of specific behavioural, physiological and psychosocial complexities associated with this special group. To preserve future drug options and sustain lifelong access to therapy, addressing non-adherence to treatment is critical to minimising acquisition of ART drug resistance and treatment failure. We review the psychosocial and developmental components that influence the course of the disease in adolescents and consider the complexities arising from perinatal exposure to ART and the growing risk of transmitted ART drug resistance in high-burden resourcelimited settings

Neurological manifestations of late onset efavirenz toxicity: a cross-sectional study of 41 patients form Pretoria, South Africa

https://drive.google.com/file/d/12qJKGjKzl95mFi9sNlWOXHRAEmCmEHMO/view?usp=sharinghttps://drive.google.com/drive/folders/1fsC_NpSTXuvTzLt0jIkHprfzdDkBJWbz?usp=sharinghttps://drive.google.com/drive/folders/10wT-Ex5avbkGINXfJ1TdD_FbVrLE5MMb?usp=sharin